AL-Yacoubi, S., AL-Izzi, M. (2022). Estimation of Serum Levels of Visfatin and Tumor Necrosis Factor-alpha in Iraqi Women with Breast Cancer. The Egyptian Journal of Hospital Medicine, 89(2), 7925-7928. doi: 10.21608/ejhm.2022.277393
Sara S. O. AL-Yacoubi; Mohand H. M. AL-Izzi. "Estimation of Serum Levels of Visfatin and Tumor Necrosis Factor-alpha in Iraqi Women with Breast Cancer". The Egyptian Journal of Hospital Medicine, 89, 2, 2022, 7925-7928. doi: 10.21608/ejhm.2022.277393
AL-Yacoubi, S., AL-Izzi, M. (2022). 'Estimation of Serum Levels of Visfatin and Tumor Necrosis Factor-alpha in Iraqi Women with Breast Cancer', The Egyptian Journal of Hospital Medicine, 89(2), pp. 7925-7928. doi: 10.21608/ejhm.2022.277393
AL-Yacoubi, S., AL-Izzi, M. Estimation of Serum Levels of Visfatin and Tumor Necrosis Factor-alpha in Iraqi Women with Breast Cancer. The Egyptian Journal of Hospital Medicine, 2022; 89(2): 7925-7928. doi: 10.21608/ejhm.2022.277393
Estimation of Serum Levels of Visfatin and Tumor Necrosis Factor-alpha in Iraqi Women with Breast Cancer
Background: Breast cancer is the most prevalent kind of female cancer among women today affects both emerging and industrialized nations. Objective: This study intended to assess the levels of Visfatin and pro-inflammatory cytokines (TNF-α) in Iraqi women who had breast cancer. Patients and methods: In this study, serum concentrations of Visfatin and TNF-α were determined using samples from 90 Iraqi women (50 patients and 40 healthy volunteers). Results: The current study's findings demonstrated that both Visfatin and TNF-α were highly elevated in patients with breast cancer (P>0.05), and they were also strongly associated. Conclusions: This study has found an association between increased levels of serum Visfatin and TNF-α and breast cancer.